Skip To Main Content
Krishna Eluri on Muck Rack

Krishna Eluri

Verified
Southern Asia
As seen in: Citeline, Daily Mail, Reuters, Yahoo News UK, Yahoo Finance, Yahoo Finance India, The Globe and Mail, TODAY, U.S. News and World Report, Firstpost, Investing.com and
Bookworm. @Arsenal Addict. Team @McLarenF1. Compulsive Theorist. All opinions mine, RTs don't imply endorsement

Get in touch with Krishna

Contact Krishna, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

FDA Device Recalls: Records Jumped 28% In 2026, But Distinct Events Barely Moved

|
By Krishna Eluri Verified
| Medtech Insight Verified
A 28% jump in FDA device recall records in 2026 looks alarming - unless you count distinct events, which rose just 2.5%, while Class I events actually fell 16%. Two firms, Medline and Olympus, and the way kitted products are counted explain most of the surge. Snapshot: Medtech '26 • Source: Alamy (Vieriu Adrian / Alamy Stock Phot/Alamy Stock Photo) Medical devices have become indispensable tools in diagnosis and treatment in the US.
Open in Who Shared Issue with article?

CMS Grants NTAP For Aidoc’s Foundation-Model AI — A First For Broad Diagnostic Tools

|
By Krishna Eluri Verified
| Medtech Insight Verified
CMS has granted Aidoc's CARE Body CT Multi-Triage an NTAP worth $137.53 per qualifying Medicare inpatient scan — the first such payment for a broad, multi-finding, foundation-model AI, covering many conditions at once rather than one disease at a time. (Shutterstock) Diagnostic AI firm Aidoc has secured a New Technology Add-on Payment (NTAP) for its CARE Body CT Multi-Triage system from the Centers for Medicare & Medicaid Services (CMS). Beginning Oct.
Open in Who Shared Issue with article?

Video Podcast - Proof of Concept: AI in Drug Discovery

|
By Krishna Eluri Verified
| Citeline Verified
Can AI and simulation make the earliest, riskiest decisions in drug discovery faster and more reliable? Krishna Bulusu spent years in oncology data science at AstraZeneca before joining Turbine as VP of Product Innovation and Strategy, where the company builds simulated cells to run experiments in silico.
Open in Who Shared Issue with article?
See all 718 licensed articles (722 Total)